About: Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 2019 (uk) article scientifique publié en 2019 (fr) im Januar 2019 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q60912348-C1959A52-B65E-42B9-AB85-2D329AD9BC4B
publication date	2019-01-10 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q60912348-3834550C-124C-4354-8539-60FE9573A11B
language of work or name	English
exact match	wds:Q60912348-6B6B2114-D51B-4478-BD5A-21443526C4C9
exact match	https://scigraph.springernature.com/pub.10.1186/s12885-019-5269-1
cites work	wds:Q60912348-0B230462-007D-493E-A59C-6510074DF14E wds:Q60912348-1E55EA29-BAAF-4F6B-A280-C5AE6EAA2625 wds:Q60912348-30F28E71-A914-495D-A13C-434FBA55AA31 wds:Q60912348-341451C6-1169-4884-B8A5-498F692A0A63 wds:Q60912348-3815F061-5721-452D-9CA4-663AC99BC324 wds:Q60912348-382BB089-182D-4FCC-9188-A19F891BF289 wds:Q60912348-3CB6BDE3-142B-487A-AA06-A6A0A03FC0AC wds:Q60912348-4361C7B1-8784-4266-A790-A2D011FF7EDF wds:Q60912348-45A11DC2-4FCB-4AAC-BF92-CBF588C4B3F8 wds:Q60912348-4D130AC6-BCD0-48A5-A17D-DA68450247E9 wds:Q60912348-4EC16CBA-CEB5-4475-A4C6-0ACB03937E8C wds:Q60912348-52D2EA04-718B-4A39-9FC5-103D18C901B3 wds:Q60912348-5581AE80-4317-4521-83DE-E523A95CA6B4 wds:Q60912348-55985824-75D5-4D45-B56F-5F740032CCC7 wds:Q60912348-5B51D21E-D04C-4AF6-B959-FD41335BA791 wds:Q60912348-6164CA57-5968-4C0B-B10A-42129D704645 wds:Q60912348-67654730-14A8-4CA7-AE73-D4B9C8F9AE10 wds:Q60912348-7444D25E-C5C3-4A19-91A7-163F5BC382A1 wds:Q60912348-81025501-4BF0-48FD-BCF8-C047E5329617 wds:Q60912348-8D60B629-DF3F-451E-A640-EB2D7E3B4799 wds:Q60912348-95946A7C-0964-45C2-8D44-02BC842E798A wds:Q60912348-981C73F2-0909-46B6-9021-9395FC5BA254 wds:Q60912348-995C9EFA-D505-4CDA-ACD2-93811F1AA2B4 wds:Q60912348-9A2D1A83-E613-44AC-B6F1-DF56348BC74E wds:Q60912348-A58A4A38-6E12-4000-9260-FE387B3316C9 wds:Q60912348-AE451803-B3BA-45C9-97F4-FB5C22562346 wds:Q60912348-AF280A2D-3B5D-44CF-875B-A2637667248B wds:Q60912348-CACE1F84-F733-454B-8819-A84ED5176A47 wds:Q60912348-D0F0BB53-DDE6-4B05-AADB-B0518356FAC5 wds:Q60912348-D312E064-D889-43ED-9027-E8D45DB6E926 wds:Q60912348-DA1AC434-66AF-449C-8EAC-277CF463163B wds:Q60912348-DE6AD143-D184-4BC2-B7D1-69EDD120B54B wds:Q60912348-E508366D-BAC1-40FD-8858-31838CE81CF0 wds:Q60912348-EBB2F395-2334-4871-A276-E119AB05F934 wds:Q60912348-EBE7D24C-DEF1-4032-AF4C-8CB088357F64 wds:Q60912348-EE78D235-225C-4783-9B18-5F813D6015A2
cites work	Paraneoplastic thrombocytosis in ovarian cancer. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study Significance of monocyte counts on tumor characteristics and survival outcome of women with endometrial cancer. Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma Lymphopenia and its association with survival in patients with locally advanced cervical cancer Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505. The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer. Poor prognosis associated with thrombocytosis in patients with cervical cancer. Circulating neutrophils may play a role in the host response in cervical cancer Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery. The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma. Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer. Decreased pretreatment lymphocyte/monocyte ratio is associated with poor prognosis in stage Ib1-IIa cervical cancer patients who undergo radical surgery Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer Prognostic significance of pretreatment plasma fibrinogen and platelet levels in patients with early-stage cervical cancer Cancer of the cervix uteri Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer Oncologic Outcomes of Stage IVB or Persistent or Recurrent Cervical Carcinoma Patients Treated With Chemotherapy at Siriraj Hospital: Thailand's Largest Tertiary Referral Center Clinical significance of changes in peripheral lymphocyte count after surgery in early cervical cancer The clinicopathological and prognostic role of thrombocytosis in patients with cancer: A meta-analysis Preoperative elevated platelet count and thrombocytosis in gynecologic malignancies The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer. The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomy. Significance of Monocyte Counts at Recurrence on Survival Outcome of Women With Endometrial Cancer. Chemotherapy Response Rates Among Patients With Endometrial Cancer Who Have Elevated Serum Platelets The prognostic significance of hematological parameters in women with uterine serous papillary carcinoma (USPC)
author name string	wds:Q60912348-F288A23F-9313-40D9-82DA-DAE00FFF65F5
author name string	Pornprom Ittiamornlert
rdfs:label	Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy (en) Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy (nl)
skos:prefLabel	Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy (en) Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy (nl)
name	Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy (en) Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy (nl)
author	wds:Q60912348-45E34602-ADAC-4780-B9C7-EE850E3B24D7
author	Irene Ruengkhachorn
title	wds:Q60912348-11FEFEB3-B343-481D-9765-F82A0708AB3B
title	Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy (en)
page(s)	wds:Q60912348-C80C154F-551B-4161-ACA8-799ABACDFEF3
page(s)	51
instance of	wds:Q60912348-E07B885F-98EE-4727-BD7E-37CC28E4C248
instance of	scholarly article
main subject	wds:Q60912348-649D0CA1-6716-46F4-8F76-9B287AC60A0C

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software